CRP and chronic obstructive pulmonary disease: However, a recent retrospective analysis by Weiss et al showed that infusion of MSCs into patients with COPD with elevated baseline CRP (as a marker of systemic inflammation) significantly reduced long‐term (>3 months) systemic inflammation and improved pulmonary function.27